HomeEGTX • STO
add
Egetis Therapeutics AB (publ)
Previous close
kr 3.40
Day range
kr 3.26 - kr 3.46
Year range
kr 3.26 - kr 9.30
Market cap
1.17B SEK
Avg Volume
507.08K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 12.70M | 4.96% |
Operating expense | 68.00M | -12.93% |
Net income | -62.90M | 16.13% |
Net profit margin | -495.28 | 20.09% |
Earnings per share | -0.20 | 33.33% |
EBITDA | -64.12M | 6.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 272.80M | 8.38% |
Total assets | 724.10M | 3.44% |
Total liabilities | 290.80M | 27.88% |
Total equity | 433.30M | — |
Shares outstanding | 359.24M | — |
Price to book | 2.81 | — |
Return on assets | -21.37% | — |
Return on capital | -28.18% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -62.90M | 16.13% |
Cash from operations | -66.10M | -19.31% |
Cash from investing | -400.00K | — |
Cash from financing | -7.70M | -1,183.33% |
Net change in cash | -78.20M | -51.55% |
Free cash flow | -53.08M | -57.61% |
About
Founded
2006
Website
Employees
38
